SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Zwiener who wrote (13)12/11/1996 9:45:00 AM
From: Michael Collins   of 1115
 
John, I do like the fact that Lidakol aborted the herpes outbreak
well during Phase III, but like you said and Lisa said when I talked
to her earlier, Lidakol can't be approved based on that solely. The
placebo actually aborted the outbreak just 37% of the time compared
to about 75% for Lidakol.

Did Lisa say anything about the KS or MC trials of Lidakol; figured they
would have at least announced something on these by now since
they started back in Jan.

Bristol-Myers Squibb abandoning all foreign marketing rights has
to be a dissapointment, but at least they didn't give up all marketing
rights!

Sincerely,

Michael Collins
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext